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ABSTRACT 
 
CHARACTERIZATION OF DNA POLYMERASE GAMMA IN THE BASIDIOMYCETOUS 
YEAST, CRYPTOCOCCUS NEOFORMANS 
Samuel Richardson Walter, M.S. 
Western Carolina University (April 2020) 
Director: Dr. Indrani Bose 
Cryptococcus neoformans is a common basidiomycetous yeast and an obligate aerobe that 
inhabits most environments across the world. C. neoformans is also an opportunistic pathogen 
capable of causing a fungal infection of the central nervous system known as cryptococcal 
meningoencephalitis. This disease is often observed in patients suffering from AIDS or other 
immune-compromising afflictions. The antifungal medications currently used to treat C. 
neoformans infections are expensive and often incapable of eradicating infection. Understanding 
vital systems in this organism are critical to the production of cheaper and more effective 
medications.  Mitochondria are a critically important organelle in aerobic organisms, generating 
more than 90% of cellular ATP. DNA polymerase gamma (PolG) is a nuclear-encoded DNA 
polymerase that has been shown in many organisms like humans, Drosophila, and 
Saccharomyces, to play a vital role in maintaining and replicating mitochondrial DNA. 
Homology searches have revealed that C. neoformans contains a single putative DNA 
polymerase gamma gene (CnMIP1).  The aims of this project were to determine the essentiality 
of this gene, and to characterize the biochemical function of the encoded protein (CnPolG). In 
order to determine if CnMIP1 was essential to the survival of this yeast, the gene was knocked 
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down in vivo using RNA interference. This showed that cryptococci are incapable of survival 
without CnPolG, thus providing evidence of the importance of CnMIP1 in C. neoformans 
viability. Although DNA sequence homology showed the presence of a polymerase and an 
exonuclease domain in CnMIP1, the function of the encoded protein had to be experimentally 
determined. For this, the CnMIP1 gene was cloned and recombinant protein was expressed in 
both bacterial (pET28 plasmid) and yeast (pRS424 plasmid) expression systems. The bacterially-
expressed protein was heavily degraded, but addition of ethanol to the media has shown 
promising results.  The yeast-produced protein, using a codon-optimized gene construct, showed 
significantly reduced levels of degradation, but this has been an unreliable expression system for 
large-scale production of this protein thus far. The polymerization ability of recombinant 
CnPolG purified from bacteria has been assayed using M13 ssDNA as template.  Additionally, it 
has been shown that this protein can utilize either tailed or untailed primers to initiate 
polymerization and performs more robustly in a low salt environment. Finally, these assays have 
also demonstrated that polymerase activity is dependent on Mg2+ or Mn2+ ions and that 
functionality increases when both cations are present. Comparing homologues from 
Saccharomyces, humans, and Cryptococcus shows the presence of two domains in CnPolG that 
are not present in the other two homologues.  Moving forward, these domains could provide 
functional insights into the regulation of mitochondrial polymerases and may serve as potential 
pharmaceutical targets if they play an essential role in CnMIP1 functionality.
 
 
Chapter I. INTRODUCTION 
 
Cryptococcus neoformans  
Fungi belong to the domain Eukarya and include an extremely diverse collection of 
species ranging from unicellular yeasts to massive systems of mycorrhizae. Cryptococcus 
neoformans is an encapsulated basidiomycetous yeast.1 It has been isolated from ecosystems 
across the world and is known to inhabit soil, plants, and animal tissues. It can be commonly 
found in the single-celled form that is capable of self-replication via budding. It is also capable 
of forming hyphae which allows for sexual reproduction and formation of basidiospores.1 C. 
neoformans produces a polysaccharide coat that is unique to the yeast that results in a clear halo 
around the yeast body when stained with India ink and allows for its rapid identification.2 
Until recently, C. neoformans existed as two separate serotypes, A and D and a third 
hybrid serotype AD. These were determined via analysis of reactivity with various polyclonal 
antibody serums.2 Serotypes B and C were also defined in this study, and eventually grouped as a 
separate species, Cryptococcus gattii. C. neoformans A and D serotypes have recently undergone 
changes in classification again. What was formerly considered C. neoformans variety 
neoformans serotype D is now considered its own species, C. deneoformans.3 In this thesis I will 
be using both C. neoformans and C. deneoformans for different experiments. 
C. neoformans is a common opportunistic pathogen in individuals suffering from 
acquired immunodeficiency syndrome (AIDS) or individuals with otherwise suppressed immune 
systems.2 In rare cases, it has been documented to have infected individuals with fully functional 
immune systems as well. Rates of C. neoformans infection increased rapidly with the rise of 
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AIDS4 and the adoption of cancer treatments involving severe immunosuppression of the 
patient.5 Currently, treatments vary depending on the mode of infection. C. neoformans 
infections are generally treated over a 2 to 4-week period with Amphotericin B deoxycholate and 
Flucytosine, and extended treatment with Fluconazole. Fluconazole treatments range from 8 
weeks to continuous treatment for the duration of the infected individual’s lifetime.4 This is 
expensive, and components of the treatment have proved potentially toxic, especially in patients 
with renal conditions.6 The complicated nature of these treatments and potential for dramatic side 
effects have driven researchers to probe the genome of C. neoformans for essential genes with 
novel domains that could serve as potential targets for pharmaceutical intervention. Currently, 
the development of designer peptides which can inhibit proteins with high specificity is making 
significant headway,7 so identifying essential proteins has more potential than ever to generate 
new pharmaceutical targets.  
Mitochondria 
Mitochondria are essential organelles in obligate aerobes. These organelles are unique in 
that they contain their own DNA (mtDNA). As a result, the mitochondria are equipped with all 
the necessary proteins for replication and repair of the mitochondrial genome. Attempts to 
explain the presence of self-replicating DNA outside of the nucleus have bolstered the theory of 
endosymbiosis.8 This theory states that mitochondria most-likely arose from an obligate 
intracellular parasite which became a mutualistic symbiosis. Over millions of years this 
relationship grew so intimate that the intracellular species eventually became completely 
dependent on its host for metabolism. In fact, the majority of the proteins and RNAs localized to 
the mitochondria are encoded by genes found in the nucleus. Of more than 1000 proteins found 
in human mitochondria, only 13 are encoded by mitochondrial DNA.9 This means that over time 
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many of the genes necessary for maintenance of the mitochondria were translocated from 
mtDNA to nuclear DNA. Why most genes were transferred to the nucleus while others remain as 
mtDNA is unclear, but it is thought that some of the mtDNA gene products may simply be too 
hydrophobic, or too large, to cross the mitochondrial membrane.10 
The mitochondrial genome is much smaller than the nuclear genome,11 and mtDNA is 
packaged as protein-DNA constructs known as ‘nucleoids’. These nucleoids are attached to the 
inner mitochondrial membrane and harbor multiple copies of the mtDNA genome each.12 
mtDNA is different from nuclear DNA in that it is not bound to histones but instead to the inner 
mitochondrial membrane.13 Without the protection of histones, and since it is stored in the same 
mitochondrial compartment where many reactive oxygen species are generated by cellular 
respiration, mtDNA is subject to up to 10 times as many point mutation events as nuclear 
DNA.14 Accumulation of mutations in the mtDNA is an important factor in aging15 and many 
mitochondrial diseases are associated with mutations of mtDNA.11 
 mtDNA exists in a circular form in some organisms, or it is contained as concatemers of 
genome units in others.12 Two theories exist on how the DNA is replicated. One states that the 
mtDNA is replicated at multiple 300 bp origin of replication sites in a bidirectional manner. The 
other states that a rolling circle mechanism is employed which creates long tandemly repeated 
mtDNA molecules.16  
DNA Polymerase Gamma   
DNA Polymerase Gamma (PolG) is a conserved protein found in all organisms that 
utilize mitochondria. The protein is nuclear encoded and belongs to the Family A polymerases17 
which include bacterial polymerases such as DNA Polymerase I from Escherishia coli. 
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Interestingly, the most closely related polymerase is T7 bacteriophage polymerase.18 Human 
PolG was first associated with mtDNA in the early 1970s19 and was identified to be localized to 
the mitochondria within the decade.20 The protein was determined to contain a 25 amino acid 
mitochondrial targeting sequence21 and localization studies eventually determined that PolG 
exclusively localized to mitochondria.22 
The PolG protein is essential in the replication and maintenance processes of the entire 
mitochondrial genome. Evidence supporting this claim has been provided by studies in multiple 
model organisms. S. cerevisiae was determined to carry a homologous PolG-producing gene, 
ScMIP1, in its nuclear DNA in 1989.23,24 Studies involving the inactivation of ScMIP1 led to 
complete loss of mtDNA and the formation of petite S. cerevisiae colonies. Furthermore, point 
mutations of critical residues within the exonuclease domain of ScPolG resulted in massive 
increase of mtDNA point mutations.25 When similar experiments were performed in mice, their 
rate of aging was rapidly accelerated.26 In human cell lines, PolG mutants lacking polymerase 
activity lead to significant mtDNA depletion.22 Depletion of mtDNA has been associated with 
mitochondrial disease including Alpers-Huttenlocher syndrome, progressive external 
ophalmoplegia, hepatocerebral syndromes and others.15,27 
In humans, PolG is a heterotrimeric holoenzyme composed of three subunits, a 140 kDa 
polypeptide (PolGA) which is responsible for 5’ -> 3’polymerase activity and 3’ –> 5’ 
proofreading exonuclease activity, and a 54 kDa homodimeric polypeptide (PolGB) which 
increases polymerization rate and decreases exonuclease activity.28  
Human PolGA contains four conserved domains including an N-terminal domain that is 
essential to polymerase function, a linker domain that aids in DNA binding and associates with 
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the PolGB subunit, a polymerase domain responsible for DNA synthesis, and an exonuclease 
domain that performs 3’ –> 5’ exonuclease activity.  
PolGB exists as a homodimer, but only one of the monomers associates with the PolGA 
subunit in the absence of DNA.29 While it has been well established that this subunit plays a role 
in increasing the processivity of PolGA,30 it has also been shown to increase the DNA affinity of 
the holoenzyme.18 PolGB provides a protective effect against enzyme inhibition of PolGA by N-
ethylmaleimide31 and reactive oxygen species.32 The PolGB subunit has also displayed the 
ability to increase the relatively low salt tolerance of PolGA.30 
Polypeptide alignment with sequences from human, rat, fruit fly and yeast show three 
conserved polymerase motifs and three conserved exonuclease motifs.17 These motifs include 
two conserved aspartic acid residues (D890 and D1135) in the first and third polymerase motifs, 
and a conserved aspartic acid and glutamic acid (D198 and E200) in the first exonuclease 
domain.24 These four residues are responsible for coordinating divalent metal cations necessary 
for polymerase and exonuclease activity. Mg2+ is the preferred cation when using DNA as a 
template while Mn2+ is the preferred cation when utilizing RNA templates.18 
Unlike human PolG, there is only a single 143 kDa subunit for PolG in S. cerevisiae. 
Even without the help of a processivity subunit, this enzyme is capable of similarly high 
processivity that the human holoenzyme is capable of.33  
 Two different mechanisms have been proposed for mtDNA synthesis by PolG. 
Synchronous DNA synthesis in which leading and lagging ends are replicated simultaneously,34 
and strand displacement in which DNA is synthesized from an origin of replication known as an 
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OH until newly synthesized DNA is displaced by the polymerase as polymerization continues to 
an origin known as a OL resulting in asymmetric synthesis of the H and L strands.
35  
Human PolG can utilize several oligonucleotide templates including primed DNA, singly 
primed M13 ssDNA31 and synthetic RNA.36 It has also been shown to exhibit reverse RNA 
transcription36 and can perform RNA-directed 3' -> 5' DNA excision and RNA-primed DNA 
synthesis.36 This wide variety of DNA and RNA related function is indicative of the massive 
responsibility this protein has in mtDNA repair and maintenance. Interestingly, this protein 
prefers different cations depending on its template18 and increases exonuclease activity as salt 
concentration increases in vitro.18  
Until recently PolG was thought to be the sole DNA polymerase localized to the 
mitochondria. Now many other polymerases have been associated with mtDNA and 
mitochondrial localization including Primpol, DNA polymerase Beta, DNA polymerase Zeta, 
DNA polymerase Eta, and DNA polymerase Theta.37 
PolG is known to work with multiple accessory proteins in mtDNA replication. These 
protein include TWINKLE, an ATP dependent mitochondrial helicase,38 topoisomerase, which 
unwinds supercoiled DNA, and mitochondrial single-stranded binding protein, which stabilizes 
single-stranded DNA.18  
A single MIP1 homologue has been identified in C. neoformans (CnMIP1). The Wallen 
lab has previously purified small amounts of this gene’s protein product (CnPolG) from bacteria 
and used this enzyme to demonstrate polymerase activity in vitro. Preliminary RNAi 
experiments in the Bose lab have suggested that CnMIP1 could be essential in C. neoformans. 
7 
 
The essentiality of CnPolG may suggest it is a good target for pharmaceutical intervention in C. 
neoformans infection. 
 In this project, I have initiated the characterization of the CnPolG protein. I have 
confirmed the essentiality of CnMIP1 using RNAi and have demonstrated that recombinant 
CnPolG is capable of DNA polymerization using singly primed M13 ssDNA. Using this assay, I 
have also demonstrated that recombinant CnPolG requires a divalent cation to function, I have 
shown that high salt concentration reduces polymerase activity, and I have provided evidence 
that CnPolG does not perform strand displacement DNA synthesis. Additionally, I have 
developed a better method of expressing recombinant CnPolG in bacteria and I have begun 
developing a method of expressing and purifying recombinant CnPolG from yeast.  
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Chapter II. MATERIALS AND METHODS 
 
Growth conditions 
E. coli strains grown on LB agar plates were incubated at 37 °C.  E. coli strains grown in 
LB broth were incubated at 37 °C with shaking at 220 rpm.  Fungal species grown on YPD, -
TRP, or 5-FOA agar plates were incubated at 30 °C. Fungal species grown in broth were 
incubated at 30 °C with shaking at 220 rpm.  
Gene sequence acquisition 
Gene sequences were obtained from FungiDB.org release 46. CnMIP1 sequence ID is 
CNAG_06769.  
Genomic DNA preparation  
C. neoformans genomic DNA was obtained using IBCN02. A 5 ml aliquot of YPD broth 
was inoculated and grown overnight at 30°C with shaking. The cells were harvested by 
centrifugation at 12,000 g. They were resuspended in 0.5 ml of extraction buffer (50 mM Tris-
HCl, pH 8; 20 mM EDTA; 1% SDS) and bead beaten for 2-minute increments with 1-minute 
incubations on ice between the bead beatings. This was repeated until 50% - 80% of the cells 
were able to be identified as broken under a light microscope. The tubes were then incubated at 
70 °C for 10 minutes, thoroughly vortexed and treated with 200 µl of potassium acetate and 150 
µl of 5 M NaCl. The solution was mixed by inverting and incubated on ice for 20 minutes before 
being centrifuged for 20 minutes at 14,500 rpm at room temperature. The supernatant was 
transferred to a fresh tube, diluted with 450 µl of chloroform and centrifuged for 10 minutes at 
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14,500 rpm at room temperature. The upper aqueous layer was transferred to a new tube and 200 
µl of 30% PEG8000 was added before incubating on ice for 10 minutes. This solution was 
centrifuged for 10 minutes at 14,500 rpm at room temperature. The supernatant was removed, 
and the pellet was resuspended in 50 µl of sterile water. 1 µl of 500 µg/ml RNase was added, and 
the solution was incubated at 37 °C for 30 minutes. 5 µl of 3 M sodium acetate and 150 µl of 
100% ethanol were added to the solution. The solution was frozen at -20 °C for 30 minutes. 
Finally, the solution was centrifuged for 10 minutes at 4 °C, the supernatant was removed, and 
the pellet was resuspended in 50 µl of sterile water. This DNA sample was stored at -20 °C. 
RNA extraction  
Before beginning the RNA extraction process all pipet tips, materials, and centrifuge 
tubes were autoclaved twice to ensure the absence of RNases. To obtain C. neoformans RNA, 
two 6 ml YPD cultures were inoculated with IBCN64 and grown overnight at 30 °C. 3 ml of 
each culture was centrifuged at 3,000 rpm for 5 minutes at 4 °C. The cell pellets were 
resuspended in 750 µl of TRIzol® in screw cap tubes with 0.4 mm glass beads. The samples 
were bead beaten 8 times for 1-minute intervals spaced apart by 2-minute incubations on ice.  
The supernatant was collected, the beads were washed with 750 µl of TRIzol®, centrifuged as 
before and the supernatant was pooled to bring the final volume of supernatant to 1 ml. The tubes 
were then incubated at room temperature for 10 minutes followed by the addition of 200 µl of 
chloroform. The samples were briefly vortexed, incubated at room temperature for 5 minutes, 
and centrifuged for 15 minutes at 12,000 rpm at 4 °C. The top layer was isolated and centrifuged 
for 10 more minutes at 12,000 rpm at 4 °C. The supernatant was diluted with an equal volume of 
isopropanol and incubated at room temperature for 10 minutes. The tubes were centrifuged at 
12,000 rpm for 10 minutes at 4 °C. The remaining supernatant was discarded, and the pellets 
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washed with 750 µl of 70% ethanol.  The tubes were centrifuged at 10,000 rpm at 4 °C for 10 
minutes. The supernatant was discarded, and the pellets were dried for 20 minutes. The pellets 
were resuspended in 40 µl of DEPC-treated water. 20 µl of 7.5 M LiCl was added to the tubes 
and incubated overnight at -20 °C. The next day the samples were centrifuged at 14,000 rpm for 
20 minutes at 4 °C. The supernatant was discarded, and the pellets were washed twice with 750 
µl of 70% ethanol. The pellets were air dried for 10 minutes and eluted in DEPC-treated water. 
The final concentrations were measured with a Nanodrop ND-1000 spectrophotometer and 
stored at -20 °C.  
cDNA First Strand DNA Synthesis  
Initial attempts to generate cDNA from IBCN64 RNA used the Thermo Scientific Verso 
cDNA synthesis Kit. 1.1 µl of the 452.5 ng/µl RNA sample was used as the user manual protocol 
suggests. The cDNA was used as template DNA in a PCR using actin primers (BLO001 and 
BLO002). This PCR was analyzed alongside of a PCR using the same primers but utilizing 
gDNA as the template primer. All PCR results from this kit were negative.  
Subsequent attempts to isolate cDNA were undertaken using Thermo Scientific 
RevertAid First Strand cDNA Synthesis Kit. 1.1 µl of the 452.5 ng/µl CAP59 RNA sample was 
used as the user manual protocol suggests. This cDNA was used as template DNA in a PCR 
using actin primers (BLO001 and BLO002). This PCR was analyzed alongside of a PCR using 
the same primers utilizing gDNA as the template primer. 
Sanger DNA Sequencing 
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DNA to be sequenced was added to an eight-strip of PCR tubes. These tubes contain 600 
ng of the template DNA and 25 pmol of primer in a total volume of 15 µl. These eight strips 
were sequenced by GENEWIZ. 
 
Transformation of C. deneoformans via electroporation 
A 30 ml culture of the IBCN43 was grown overnight in the appropriate growth media. 
The culture was then diluted to 2x106 cells/ml. The cells were grown to approximately 6x106 
cells/ml and harvested via centrifugation at 3000 g at 4 °C. The cells were then resuspended in 
50 ml chilled water and pelleted as before twice in order to wash away all growth media. The 
cells were then resuspended in 50 ml of cold electroporation buffer (10 mM Tris-HCl, pH 7.5, 1 
mM MgCl2, 270 mM sucrose). 200 µl of 1 M DTT was added to the electroporation buffer and 
the mixture was incubated for 15 minutes on ice. The cells were then pelleted as before and 
resuspended in 50 ml electroporation buffer. The cells were once again pelleted as before and the 
residual electroporation buffer was stirred back into the cells before they were transferred to the 
pre-chilled electroporation cuvette. 60 µl of cells were transferred to each electroporation cuvette 
and the appropriate DNA was added to the cells and stirred into the cells. The electroporator was 
set to the following: 0.5 kV, 25 µF and 1000 or ∞ ohms. Ideal pulse lengths or time constants are 
between 15-25 ms. Samples were then resuspended in YPD broth for 3 hours in order to recover 
from electroporation before being plated on the appropriate selective media.  
Electroporation of JEC21 with the pIBB103 and pIBB103-CnMIP1 
The pIBB103 and pIBB103-CnMIP1 plasmids were linearized by restriction digestion 
using I-SceI. The reactions contained 20µl of each plasmid DNA, 8µl of 10xCutsmartTM buffer, 
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2µl of I-SceI, and 50µl of water. The linearized DNA aliquots were purified using Wizard® Plus 
SV DNA Cleanup Kit (Promega) and resuspended in 35 µl of water. Three electroporations were 
performed using 5 µl of linearized pIBB103, 4 µl of pIBB103-CnMIP1, and 3 µl of water as 
control. The time constants of these electroporations were 36.3 ms, 30.8 ms and 30 ms 
respectively. The electroporated cells were plated on YPD-neo plates and allowed to grow for 3 
days.  
Cloning CnMIP1 cDNA in pTOPO 
After isolating cDNA from IBCN64, a PCR reaction was performed using the cDNA as 
template DNA and BLO179 and BLO180 as primers to amplify the full-length CnMIP1 gene. 
The reaction mixture for this PCR reaction contained 1 µl of cDNA template, 1 µl of each 
primer, 1 µl dNTP, 5 µl of 5x Q5 reaction buffer, 0.25 µl of Q5 polymerase and 15.75 µl of 
water. The thermocycler program was set to the following: 94 °C 30 s; 30 x (98 °C 10 s, 57 °C 
30 s, 72 °C 3 m); 72 °C 15 m. The resulting PCR product was purified using the Wizard® Plus 
SV DNA Cleanup Kit (Promega). This CnMIP1 PCR fragment was used in a Zero Blunt Topo 
reaction in order to clone the gene into pTOPO. This reaction mixture consisted of 2 µl CnMIP1 
cDNA, 1 µl salt solution, 1 µl TOPO vector, and 2 µl of water.  This reaction mixture was 
incubated at room temperature for 15 minutes and subsequently transformed into subcloning 
efficiency cells. The transformation was carried out using 2 µl of pTOPO reaction mixture in 20 
µl of subcloning efficiency cells and plated on LB plates containing 100 µg/ml kanamycin. 
Resulting colonies were screened for proper insertion of the full-length CnMIP1 fragment by 
PCR with primers BLO179 and BLO180.  The reaction mixture for this was 1 µl of harvested 
DNA, 1 µl of BLO179, 1 µl of BLO180, 5 µl of 2x Taq polymerase PCR master mix and 2 µl of 
water.   
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T4 ligation of EcoRI digested CnMIP1 from pTOPO and EcoRI digested pRS424 
The pRS424 plasmid was obtained from the Wallen lab. 2 µl of this plasmid was 
transformed into 20 µl of subcloning efficiency cells. The resulting colonies were grown 
overnight in a 5 ml culture and the plasmids were recovered via column purification using the 
Wizard® Plus SV Miniprep DNA Purification Kit (Promega). The resulting DNA aliquot was 
used in a restriction digestion with EcoRI-HF. The reaction mixture used contained 25 µl of 
pRS424 plasmid, 8 µl of Cutsmart 10x buffer, 3 µl of EcoRI-HF, and 50 µl of water.  This 
reaction mixture was incubated at 37 °C for 5 hours. 2 µl of shrimp alkaline phosphatase (SAP) 
was added to the reaction mixture and incubated at 37 °C for 35 minutes. The reaction was 
terminated by incubating the mixture at 65 °C for 15 minutes. The DNA in this reaction mixture 
was then purified using the Wizard® SV DNA Cleanup Kit (Promega) and eluted in 35 µl of 
water.  
Another restriction digestion was performed using pTOPO-CnMIP1 as the DNA to be 
digested. This reaction mixture included 15 µl pTOPO-CnMIP1 (1), 8 µl of Cutsmart 10x buffer, 
3 µl of SmaI and 49 µl of water.  This reaction mixture was incubated at 37 °C for 5 hours. 3 µl 
of EcoRI-HF was then added to the reaction mixture and it was incubated at 37 °C for an 
additional 5 hours. The reaction mixture was then subjected to gel electrophoresis on a 0.8% 
agarose gel at 100 V for 30 minutes. The DNA band at 4.5 kb was excised and purified using the 
Wizard® SV DNA Cleanup Kit (Promega) and eluted in 40 µl of water.  
A ligation reaction was performed using the reagents prepared above. This reaction 
mixture included 2 µl of SAP treated pRS424 and 7 µl of gel purified CnMIP1, 2 µl of 10x T4 
DNA Ligase buffer, 1 µl of T4 DNA ligase, and 8 µl of water. The reaction mixture was 
incubated at room temperature for 1 hour and then incubated at 16 °C overnight. The reaction 
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was terminated by incubating the mixture at 65 °C for 15 minutes. 5 µl of the ligation mixture 
was used in a transformation with 40 µl of NEB® 5 alpha cells. Twenty of the resulting colonies 
were grown in 5 ml LB broth with 100 µg/ml ampicillin. The plasmids were harvested from 
these cells using the Wizard® Plus SV Miniprep DNA Purification Kit (Promega). The resulting 
DNA aliquots were screened for proper insertion and proper orientation of CnMIP1 using DraIII. 
DraIII was used because if the insert was present in the pRS424 vector in the correct orientation, 
the resulting band would be approximately 500 bp. If the insert was oriented backwards, the 
resulting band would be approximately 4.5 kb.  
Sequencing of pRS424-CnMIP1 #18 
The pRS424-CnMIP1#18 construct was sequenced using three primers in three 
independent sequencing reactions. The Exon1F and Exon4R primers were used to confirm the 
full-length of protein was inserted into the pRS424 vector. The Exon1R primer was used to 
assess the junction between CnMIP1 and the N-terminal GST tag. All sequencing reactions were 
set up as described above.  
pRS424-CnMIP1 #18 unwanted segment removal by PCR 
To remove the unwanted 70 bp segment from our expression vector, a reverse 
complementary primer was made of Exon1F (BLO245). A PCR reaction was performed using 
pRS424-CnMIP1 #18 as the template with BLO245 and Exon1F. This reaction mixture included 
1 µl of 4.8 ng/µl pRS424-CnMIP1#18, 1 µl of 1 µM BLO245, 1 µl of 1 µM Exon1F, 0.35 µl of 
2000 U/ml Phusion polymerase, 4 µl of 5x Phusion GC buffer, 1 µl of 10 mM dNTPs, and 13.45 
µl of water. This reaction resulted in a product of approximately 11kb. The DNA product was 
excised, and gel purified using the Wizard® Plus SV DNA Cleanup Kit (Promega). 
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pRS424-CnMIP1 intramolecular HiFi 
The linear purified product resulting from the pRS424-CnMIP1#18 correction PCR was 
utilized in a HiFi reaction. The reaction mixture included 3 µl of 31.9 ng/µl PCR product, 5 µl of 
the 2x NEBuilder HiFi Master Mix, and 2 µl of water. This reaction was incubated at room 
temperature for 5 minutes. 5 µl of the reaction mixture was transformed into NEB® 5-alpha cells 
and plated on LB plates with 0.1 mg/ml ampicillin. Resulting colonies were screened using Sal1 
and correct sequences were confirmed by sanger sequencing.  
Homologous recombination in S. cerevisiae 
 In order to perform homologous recombination in yeast, a fresh culture of IBF42 was 
grown overnight. The transformation was initiated by centrifuging 0.5 ml of broth culture in a 
sterile microcentrifuge tube. The supernatant was discarded before stirring in 100 µg of salmon 
sperm DNA, 1 µg of PCR product made with BLO256 and BLO257, and 0.5 µg of EcoRI and 
XhoI digested pRS424 to the cell pellet. 0.5 ml of PLATE solution (40% PEG 3350, 0.1 M LiAc, 
10 mM Tris HCl pH 7.5, 1 mM EDTA) were added and the tube was vortexed for 10 seconds. 57 
µl of DMSO were added to the solution and vortexed for 2 seconds. The solution was left at 
room temperature for 15 minutes. The solution was then incubated in a 42 °C water bath for 15 
minutes. The solution was centrifuged at 10,000 rpm for 15 seconds. The cell pellet was 
resuspended in 200 µl of PBS and plated on selective media.  
Bacterial Overexpression of recombinant Protein 
The pET28a-CnMIP1 protein expression plasmid was obtained from the Wallen lab. This 
expression plasmid encodes six histidines which are added to the N-terminus of the CnPolG 
protein. The protein expression plasmid was transformed into BL21(DE3) cells, and the one 
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colony of transformed BL21(DE3) cells were grown overnight in 100 ml starter culture of LB 
with 50 µg/ml kanamycin. 10 ml of the starter culture was used to inoculate six 1-liter cultures of 
LB with 50 µg/ml kanamycin to an OD600 of 0.6. Protein production was then induced by the 
addition of IPTG to a final concentration of 0.5 mM. After 3 hours of induction at 37 °C, the 
cells were harvested by centrifugation for 5 min at 6000 rpm in a Sorvall SLA-3000 rotor at 4 
°C. Cell pellets were then resuspended in 50 ml of Ni-Buffer A (50 mM Tris, 0.5 M NaCl, 0.1 
mM EDTA, 5% glycerol) and stored at -80 °C.  
Purification of the Bacterially Expressed Protein  
The frozen cells were thawed in a room temperature water bath. The solution was then 
sonicated on ice for 1-minute intervals 5 times with 1.5-minute rests in between. The solution 
was then centrifuged at 16000 rpm for 45 minutes at 4 °C in a Sorvall SS-35 rotor. The 
supernatant was diluted with Ni-Buffer A (50 mM Tris pH 8.0, 0.5 M NaCl, 0.1 mM EDTA, 5% 
glycerol) to 150 ml loaded onto a nickel chromatography column. The protein was eluted with 
Ni-Buffer B (0.25 M imidazole, 50 mM Tris pH 8.0, 0.5 M NaCl, 0.1 mM EDTA, 5% glycerol) 
and visualized with SDS-PAGE and Coomassie blue staining. The eluted product was 
equilibrated in 2 liters of 90% Q-Buffer A (20 mM Tris pH 8.0, 1 mM EDTA, 1 mM BME, 10% 
glycerol) and 10% Q-Buffer B (1 M NaCl, 20 mM Tris pH 8.0, 1 mM EDTA, 1 mM BME, 10% 
glycerol) overnight at room temperature. The equilibrated solution was loaded onto the ion-
exchange column and then eluted in 3 ml aliquots starting at 10% Q-Buffer B and ending at 80% 
Q-Buffer B over 200 ml. The product was examined using SDS-PAGE and Coomassie blue 
staining. The first three 3 ml fractions of the ion exchange elution were concentrated by 
centrifugation at 4000 g using an Amicon® Ultra 15 mL Filter. 
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SDS−PAGE 
8% polyacrylamide gels were made as follows: 3.68 ml diH2O, 2.133 ml 30% 
acrylamide, 2.027 ml of R buffer (250 mM Tris HCl, 192 mM Glycine, 1% SDS pH 8.3), 80 µl 
10% SDS, 80 µl 10% APS, 4.8 µl TEMED were mixed together in a small beaker. This solution 
was poured into a BioRad gel stacking box and allowed to solidify for 15 minutes. 2.1 ml diH2O, 
0.5 ml 30% acrylamide, 0.38 ml of S buffer (500 mM Tris HCl, 192 mM glycine, 1% SDS), 30 
µl 10% SDS, 30 µl 10% APS, 3 µl TEMED were added to another small beaker. This solution 
was poured on top of the existing solidified gel and a 10 or 15 prong comb was used to produce 
the loading wells. The wells were loaded with the appropriate solution along with dye to 
visualize the progress of the electrophoresis. BioRad gel boxes were used at variable voltage 
settings for variable lengths of time.  
Western Blot Analysis.   
Proteins or lysates of interest were first separated by SDS−PAGE and then transferred to 
a PVDF membrane. All antibodies were diluted with TBS-T. The membrane was incubated with 
a 1:1000 dilution of primary GST antibody (ThermoScientific, Cat # MA4-004) or 1:10,000 
dilution of primary His6 antibody (ThermoScientific, Cat # MA1-21315) overnight at 4 °C with 
shaking. These incubations were followed with three 5-minute washes with TBS-T and then a 
30-minute incubation at room temperature with 1:10,000 dilution of secondary antibody 
conjugated to horseradish peroxidase. The membrane was once again washed three times for 5 
minutes each with TBS-T. The colorimetric substrate was mixed, immediately applied to the 
membrane, allowed to incubate for 4 minutes and then imaged using a Bio-Rad imager.  
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A similar method of western blot analysis was also performed using HisProbe™-HRP. 
This probe replaces the primary antibody incubation step. The HisProbe™-HRP is diluted 
1:5000 with TBS-T. It is then poured onto the PVDF membrane and incubated at room 
temperature for 1 hour. The membrane is washed three times for 5 minutes before incubation 
with the secondary antibody and colorimetric substrate as above.  
Preparation of M13 bacteriophage  
M13 ssDNA was isolated from XL-1 blue E. coli cells infected with M13 bacteriophage. 30 µl of 
fresh XL-1 blue cells were streaked on LB agar plates with 10 µg/ml tetracycline and grown 
overnight. One colony was used to inoculate a 25 ml culture of LB broth with 10 µg/ml 
tetracycline and grown overnight. 1.5 ml of the starter culture was used to inoculate 150 ml of 
LB broth with 10 µg/ml tetracycline. After two hours, 15 µl of 1.6 x 1010 pfu/ml stock M13 virus 
was added to the 150 ml culture. The viral infected E. coli cells were incubated for 5 hours. The 
cells were centrifuged at 3000 rpm and the supernatant was removed and filtered with a 0.22 µm 
filter. The final solution was stored at 4 °C.  
Purification of M13 ssDNA  
10 g of solid PEG 8000 along with 7.5 g of NaCl were added to filtered M13 supernatant. 
The solution was stirred gently on ice for 30 minutes. The solution was transferred to 50 ml 
conical tubes. The tubes were centrifuged at 4500 rpm for 30 minutes. The supernatant was 
discarded, and each pellet was resuspended into a single 3 ml aliquot of TE. Three volumes of 
0.1 M NaOH, 1% SDS solution were added and swirled. 1.5 volumes of 3M potassium acetate 
pH 5.0 were added and incubated on ice for 30 minutes. The solution was transferred to 1.5 ml 
Eppendorf tubes and centrifuged at 13000 rpm for 10 minutes in a cold centrifuge. The 
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supernatant was transferred into fresh conical tubes. 1 volume of cold 95% ethanol was added 
and allowed to incubate on ice for 30 minutes. The solution was transferred to 1.5 ml Eppendorf 
tubes and centrifuged at 13000 rpm in cold centrifuge for 20 minutes. The supernatant was 
poured off and 500 µl of cold 75% ethanol was added. Tubes were inverted once and centrifuged 
at 13000 rpm for 10 minutes. The supernatant was poured off and the tubes were inverted until 
all ethanol was evaporated. Once completely dry, 25 µl of TE pH 8.0 was added to each tube and 
placed at 4 °C overnight to resuspend. DNA quantification was performed with a Nanodrop ND-
1000 spectrophotometer.  
Annealing Primers to M13 DNA 
The annealing reactions were typically set up in 50 µl aliquots containing 1x annealing 
buffer (10 mM Tris pH 8.0, 50 mM NaCl, 1 mM EDTA), 100 nM M13 ssDNA, and 120 nM 
M13 primer. 1 liter of water was then brought to a boil in a 1-liter beaker. The reaction mixtures 
were placed in the beaker with a floater and the beaker was allowed to cool to 30 °C. 
M13 ssDNA Polymerase assay 
40 µl reaction mixtures were made containing 1x assay buffer (50 mM Tris pH 7.5, 25-
100 mM NaCl, 1 mM DTT, 100 µg/ml BSA, 1 mM dNTPs, 0-10 mM MgCl2, 0-10 mM MnCl2, 
100 nM annealed M13 ssDNA). Each reaction mixture was preheated to 37 °C using a water 
bath before the enzyme was added. The addition of enzyme began the reaction and the reactions 
were maintained at 37 °C. At varying time points, 10 µl of the reaction mixture was removed and 
added 10 µl of 2x quench buffer (50 mM EDTA, 0.2% SDS, 10% glycerol) to stop the reaction. 
Each quenched sample was then loaded onto a 1% agarose gel with ethidium bromide and ran at 
20 V for 16 hours. The gel was imaged using Biorad ChemiDoc MP imager. 
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Chapter III. RESULTS 
 
I.  Determining the essentiality of CnMIP1 using RNA interference in C. deneoformans 
C. deneoformans is an obligate aerobe that is incapable of survival without its 
mitochondria. Mitochondria rely on genes encoded by mtDNA to undergo cellular respiration. In 
other organisms, the protein primarily responsible for replicating and maintaining mtDNA is 
DNA polymerase gamma. This protein is ultimately derived from the nuclear encoded CnMIP1 
gene, and it is possible to knockdown protein levels by taking advantage of RNA interference, a 
process that destroys mRNA containing a specific sequence.  
A former graduate student in the lab, Joshua Boggs, cloned a segment of the CnMIP1 
coding sequence into the RNAi vector, pIBB103, which is designed to produce double-stranded 
RNA (dsRNA) using opposing galactose-inducible GAL7 promoters. The configuration of these 
promoters causes any DNA sequence between them to be transcribed, producing complementary 
RNA fragments that can bind to each other to form dsRNA, activating the process of RNAi. The 
gene of interest was inserted between the two promoters and adjacent to the URA5 gene fragment 
(Figure 1). 
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Figure 1. pIBB103-MIP1i vector used for MIP1 RNAi.  The opposing GAL7 promoters (in green) 
flank a URA5 fragment (in blue), and unique NdeI and SpeI sites for cloning the gene of interest. 
 
The silencing of URA5 allows the transformed cells to grow in the presence of 5-FOA. 
The YPG-neo plates are used as a control to show that the induction of the GAL7 promoters is 
not lethal to the cell population in the absence of 5-FOA (see Discussion for possible 
explanation).  
22 
 
 
Figure 2. CnMIP1 RNAi. Growth of pIBB103 (top) and pIBB103-MIP1i (bottom) on YPG-neo 
(A) and 5-FOA-gal-neo (B) media 48h after replica plating. 
 
As seen in Figure 2A, the pIBB103 plasmid allows for growth in the presence of the 
drug, G418.  Once replica plated on 5-FOA-gal the pIBB103 colonies survive while 90% of the 
pIBB103-CnMIP1 colonies do not (Figure 2B). This result strongly suggests that CnMIP1 plays 
an essential role in C. neoformans.   
II.  Bacterial expression and purification of CnPolG 
In order to determine the structure and function of CnPolG, large quantities of protein are 
required. To produce this protein, the Wallen lab generated two plasmids that facilitate the 
overexpression of CnPolG in E. coli. The first plasmid (pET28a-CnMIP1) utilizes a 6-histidine 
(His6) tag on the N-terminal end of CnPolG to allow purification of the protein by nickel column 
chromatography. Unfortunately, the majority of the recombinant CnPolG protein expressed using 
this plasmid was degraded in E. coli, resulting in contamination of the final purified protein 
product with possibly non-functional His6-tagged CnPolG protein fragments. In order to acquire 
pure, undegraded CnPolG, a second plasmid (pET28a-CnMIP1-His-Strep) was constructed 
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which tags the recombinant CnPolG with a His6 tag at the N-terminus and a Strep-tag® at the C-
terminus. This allows for full-length protein products to be isolated from degraded products by 
ensuring the protein contains both the His6 tag on one end and the Strep-tag® on the other.  This 
plasmid made it possible to isolate full-length CnPolG, but it did so very inefficiently. Using the 
double-tagged plasmid, low milligram quantities CnPolG were purified from 27 liters of 
transformed E. coli culture. This protein was used in an M13 rolling circle assay to assess its 
polymerase activity (Figure 13).  
II. A Bacterial expression of CnPolG: in pET28a-CnMIP1induced at 37˚C 
Because very low quantities of protein were able to be isolated using pET28a-CnMIP1-
His-Strep, optimizing the E. coli growth conditions to minimize protein degradation when 
expressed using the pET28a-CnMIP1 plasmid was necessary. To set a baseline of expression and 
purification, the induction protocol that had been used previously by the Wallen lab was 
followed. Briefly, CnPolG was expressed in E. coli using 6 liters of media.  Expression was 
induced with IPTG at 37 ˚C (see Materials and Methods).  
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Figure 3. Purification of His6-tagged CnPolG at 37 °C. (A) Protein profile obtained using a Ni-
column.  The profile of proteins in uninduced cells, induced cells, flow-through after Ni-column 
binding, and the progressive elutions with 3 ml of 20 mM imidazole were visualized using an 8% 
SDS-PAGE gel stained with Coomassie blue. Each lane contains 10 µl of the indicated aliquot. 
(B) Protein profile obtained using an Ion-Exchange column with increasing salt washes. 10µl of 3 
ml aliquots of Ion exchange column elution fractions using increasing NaCl concentration were 
visualized using an 8% SDS-PAGE gel stained with Coomassie blue. The full-length recombinant 
protein tagged with His6 has a mass of 158.7 kDa. 
 
A. 
B. 
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 As shown in Figure 3A, an SDS-PAGE gel stained with Coomassie Blue showed the 
presence of an approximately 158 kDa protein in the induced lane that was not present in the 
uninduced lane. Since the His6 tagged CnPolG protein is 158.7 kDa in size, this suggests that the 
addition of IPTG allowed for production of CnPolG in E. coli transformed with the pET28a-
CnMIP1 plasmid. The flow-through lane indicated that very little of the protein product passed 
over the nickel column without binding.  In contrast, the presence of a band of the correct size in 
the elution 1-4 lanes indicated that full-length CnPolG protein appeared to come off the Ni-
column in the presence of 20 mM imidazole. The presence of bands of lower size was most 
likely due to heavy protein degradation which occurs during expression.  
 To try and eliminate some of the degraded protein products obtained in the elution from 
the Ni-column, a second purification step was performed. The GE Life Sciences Hitrap Q 5ml 
column used for this eluted protein in 3 ml fractions in the presence of increasing NaCl 
concentration from 100 mM to 800 mM to separate and purify proteins based on charge. A 
Coomassie blue-stained gel of the fractions (Figure 3B) showed that the majority of the full-
length His6-tagged CnPolG eluted within the first three fractions (or 9 ml). These fractions (1-3) 
also showed less degraded protein products than that obtained from the Ni-column. These 
fractions were pooled together, dialyzed overnight, (see Materials and Methods), and then 
concentrated using an Amicon® Ultra 15 ml filter.  The protein that was obtained had a final 
concentration of 1.65 mg/ml and was later used in functional assays.   
II. B Bacterial expression of CnPolG: in pET28a-CnMIP1 induced in the presence of ethanol 
 As expression and purification of CnPolG from the pET28a-CnMIP1 plasmid at 37 °C 
did not produce large quantities of undegraded protein, it was decided to explore different 
conditions which could potentially lessen the rate of protein degradation. One of these conditions 
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was to grow E. coli in the presence of increasing ethanol concentrations before induction of the 
protein with IPTG.39 Ethanol is an amphipathic molecule. When exposed to bacterial cell 
membranes this causes changes in membrane fluidity, membrane transport and membrane lipid 
composition.40 This causes increase in DNA synthesis41 which could contribute to increased 
protein expression levels in the presence of ethanol. 
 
Figure 4. Expression of His6-tagged CnPolG in the presence of ethanol at 37 °C and benzyl 
alcohol at 20 °C. Two E. coli colonies induced in the presence of ethanol at 37 °C and in the 
presence of benzyl alcohol at 20 °C visualized by 8% SDS-PAGE stained with Coomassie blue. 
A band present at approximately 158 kDa indicates protein expression is induced successfully 
with IPTG. Darkness of this band increases as the concentration of ethanol increases. 
 
Using a protocol developed by Chhetri et. al.,39 it has been shown that the addition of 
ethanol to LB+Kan media effectively increased the quantity of protein produced by E. coli. 
Figure 4 showed that the addition of 1% ethanol slightly increased the darkness of a band present 
at 158 kDa, while the darkness of the bands in the 2% and 3% lanes indicated a dramatic 
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increase the amount of protein produced. This experiment was performed in duplicate in order to 
ensure the results are reproducible. Western blots utilizing anti-His6 antibodies were performed 
using these samples, but failed to produce any result. 
 To demonstrate the validity of adding ethanol to the E. coli growth media, six liters of 
media with 3% ethanol inoculated with bacteria containing our pET28a-CnMIP1 plasmid was 
made. Once the bacteria had been induced, harvested and lysed, the lysate was passed through a 
nickel column. The resulting elution from this nickel column was void of the CnPolG protein, 
which may have been due to the age of the nickel column used. Since this result was 
inconclusive, purification of the protein induced under these growth conditions should be 
repeated. 
II. C Bacterial expression of CnPolG: in pET28a-CnMIP1-His-Strep induced in the presence of 
ethanol 
 The plasmid pET28a-CnMIP1-His-Strep had been used previously to purify small 
amounts of double-tagged full-length CnPolG protein.  Having demonstrated that the addition of 
ethanol effectively increases the expression level of recombinant protein using pET28a-CnMIP1, 
the same protocol was used with pET28a-CnMIP1-His-Strep to determine whether this protocol 
would increase overall protein expression as well as decrease levels of protein degradation. 
28 
 
 
 
Figure 5. Expression of His6-tagged/Strep-tagged CnPolG in the presence of ethanol and benzyl 
alcohol at 37°C. (A) Protein lysate of one E. coli colony transformed with pRS424-CnMIP1-His-
Strep and induced in the presence of ethanol or benzyl alcohol at 37 °C visualized using 8% 
B. 
A. 
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SDS-PAGE stained with Coomassie blue. A band present at approximately 158 kDa in the 
induced lane indicates protein expression is induced successfully with IPTG. Darkness of this 
band increases as the concentration of ethanol increases. (B) Western blot performed with 
HisProbe™-HRP conjugate shows that increasing ethanol concentration to 3% has condensed 
the protein smear into a tight band.  
 
The results of the SDS-PAGE gel (Figure 5A) indicated similar results to the pET28a-
CnMIP1. A protein band near 158 kDa appeared in the induced lane and increased in darkness at 
the higher ethanol concentrations, but in the presence of benzyl alcohol seems have diminished 
this effect. This provided evidence that ethanol could be used to make protein expression more 
efficient using the pET28a-CnMIP1-His-Strep.  
 The subsequent anti-His6 western blot (Figure 5B) shows that little protein is induced in 
the absence of ethanol. There was more His6-tagged protein of higher molecular mass in the 
induced samples.  There was good expression of the full-length protein and very little 
degradation (indicated by the absence of smaller His6-tagged bands) in the protein sample 
induced in the presence of 3% ethanol. The 3% ethanol lane was also better than the sample 
induced in the presence of benzyl alcohol. Therefore, it seems that the addition of 3% ethanol to 
the growth media before induction with IPTG gave the most desirable results when expressing 
this recombinant protein.  
III. Expression of CnPolG in the yeast, S. cerevisiae 
 Degradation is common when expressing large, multi-domain proteins in E. coli, a 
prokaryotic organism. In this case, the protein being expressed was a relatively large protein that 
is native to a eukaryotic organism. Utilizing a more closely related eukaryotic organism for 
protein expression may reduce or eliminate protein degradation due to the availability of 
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eukaryotic chaperone proteins. S. cerevisiae, a single-celled eukaryote, is commonly used for 
recombinant protein expression. Here this yeast was used for expression of recombinant CnPolG. 
III. A Obtaining C. neoformans cDNA 
The budding yeast, S. cerevisiae, is one of a few eukaryotes that does not efficiently 
perform intron splicing. Therefore, in order to express CnPolG in this organism, the introns in 
the CnMIP1 gene had to be removed by cloning the cDNA version in the yeast plasmid, pRS424.  
Many problems were encountered during the process of creating the pRS424-CnMIP1 plasmid. 
In order to try and circumvent some of these issues, a PCR product of the coding sequence of 
CnMIP1 had to be obtained. This was done by using mRNA found in the C. neoformans cytosol 
as a template for reverse transcription. RNA was isolated from cap59 cells. The extracted RNA 
was used to generate cDNA using reverse transcriptase (see Materials and Methods). This DNA 
was used in a PCR reaction to confirm the absence of introns in the cDNA using BLO1 and 
BLO2 as primers to amplify the ACT1 gene.  
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Figure 6. Confirmation of intron absence in C. neoformans cDNA. (A) Results of PCR 
amplification of ACT1 from cDNA, and gDNA.  ACT1 was amplified using BLO1 and BLO2 to 
assess the presence of introns from cDNA and gDNA and visualized on a 0.8% agarose gel.  
Amplification of GAPDH served as the positive control using primers from the Revertaid First 
A. 
B. 
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Strand DNA Synthesis Kit (ThermoScientificTM). (B) Alignment of C. neoformans gDNA (top 
sequence) and Sanger sequencing data of the C. neoformans cDNA template (bottom sequence). 
 
The result shown in Figure 6A clearly showed a smaller band in the cDNA lane. The 
absence of introns was further confirmed via Sanger sequencing, as seen by missing intronic 
sequence in an alignment of the gDNA (top strand) vs. cDNA (bottom strand) in Figure 6B. 
III. B Making of pTOPO-CnMIP1 from CnMIP1 cDNA 
 In order to maintain the cDNA sequence of CnMIP1, a Zero BluntTM TOPOTM cloning kit 
was used to insert the CnMIP1 DNA fragment into pTOPO (see Materials and Methods). 
Approximately 50 colonies were generated using this protocol and six of the colonies were 
screened for presence of CnMIP1. All six of the colonies were confirmed to contain CnMIP1. 
Maintaining this gene sequence allowed for easy amplification and isolation of CnMIP1 in the 
future by restriction digestion with EcoRI. 
 
Figure 7. Confirmation of CnMIP1 in pTOPO-CnMIP1 by PCR. 0.8% agarose gel containing PCR 
of pTOPO-CnMIP1 transformant DNA using BLO179 and BLO180. Full-length CnMIP1 cDNA 
is 4359 bp.  
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 Figure 7 represents a PCR used to confirm the presence of CnMIP1 in two pTOPO 
plasmids recovered from separate transformant colonies. The presence of a band at 4359 bp 
indicates that CnMIP1 has been successfully integrated thus creating pTOPO-CnMIP1.  Moving 
forward CnMIP1 was obtained from this plasmid using EcoRI and XhoI restriction enzymes for 
use in ligation reactions with pRS424.  
III. C Cloning CnMIP1 cDNA EcoRI site alone of pRS424 vector  
CnMIP1 was isolated from pTOPO-CnMIP1 by restriction digestion with EcoRI and 
subsequent gel purification. This DNA was then used in a ligation reaction with pRS424 
linearized with EcoRI (see Materials and Methods). The transformant colonies generated by this 
process were screened using DraIII restriction enzyme. This restriction enzyme was chosen 
because it could be used to determine the orientation of CnMIP1 with relation to pRS424. 
Plasmids which contain the CnMIP1 gene in the correct orientation would present two DNA 
bands at 10.8 kb and 500 bp, as seen lane 18 (Figure 8). Plasmids with CnMIP1 in the incorrect 
orientation would present two DNA bands of 7.3 kb and 4 kb, as seen in lanes 11 and 20 (Figure 
8).  
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Figure 8. Transformant colony screen for presence of pRS424-CnMIP1. Restriction digestion of 
plasmids harvested from colonies transformed with ligation reaction of EcoRI digested CnMIP1 
and EcoRI digested pRS424 were visualized using 0.8% TAE-agarose gel showing restriction. 
 
 
 Figure 8 reveals that only a single colony (lane 18) out of the 20 that were tested 
contained CnMIP1 in pRS424 in the correct orientation. Lanes 11 and 20 contained the insert in 
the incorrect orientation.  
III. D Yeast expression of GST ScMIP1 and CnMIP1#18 
 The pRS424-CnMIP1#18 plasmid that was produced allowed for plasmid maintainence 
and amplification in bacteria, while also allowing recombinant protein to be produced in S. 
cerevisiae. This plamid would also tag the protein with GST to allow column purification and 
western blotting. The next step was to assess the expression of  GST, ScPolG and CnPolG using 
pRS424, pRS424-ScMIP1 and pRS424-CnMIP1#18 respectively. pRS424-ScMIP1 was acquired 
from the Wallen lab. 
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Figure 9. Expression of GST, ScPolG, and CnPolG in S. cerevisiae at 30 °C. Western blot was 
performed with GST antibody. Protein expressed using pRS424, pRS424-ScMIP1, and pRS424-
CnMIP1#18 are represented. A band at 25 kDa is expected from GST, a band at 160 kDa is 
expected from ScPolG, and a 183 kDa band is expected from CnPolG. 
 
The first attempt to express CnPolG in S. cerevisiae produced unexpected results. GST 
expressed robustly at the expected size at all time points past 0 hours. Small amounts of ScPolG 
can be observed at the expected size after 3 and 5 hours, but after 19 hours the protein has 
disappeared. The CnPolG lanes show protein bands at an unexpected size. The expressed protein 
is slightly larger than GST. This puzzling result gave reason to analyze pRS424-CnMIP1#18 
with more scrutiny. Sequencing data revealed that a 131 bp portion of unwanted DNA had been 
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ligated into the plasmid between the GST tag and CnMIP1. This extra DNA caused a frameshift 
in the translation process and resulted in a truncated recombinant protein.  
III. E Correcting the pRS424-CnMIP1#18 
 The pRS424-CnMIP1#18 plasmid had to be corrected in order to move forward 
expressing CnPolG in S. cerevisiae. In order to correct this plasmid, the Exon1F primer was used 
with BLO245 in a PCR reaction to remove the unwanted DNA and the PCR product was ligated 
to itself using NEBuilder HiFi cloning (see Materials and Methods). The newly synthesized 
plasmids were confirmed with Sanger sequencing to contain CnMIP1 in the correct orientation 
and with no unwanted DNA included. 
III. F Native-CnMIP1 expression. 
 Now that pRS424-CnMIP1 had been obtained, it was pertinent to make sure that the 
protein would express robustly and that protein products were not degraded as heavily as in 
bacteria.  
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Figure 10. Expression of CnPolG in S. cerevisiae with pRS424-CnMIP1. Western blot performed 
with GST antibody. pRS424-CnMIP1 was the expression vector used. This gel represents the 
results of induction of two individual transformant colonies 3 hours 4 hours and 19 hours after 
induction. 
 
 Figure 10 revealed that our protein was expressing very slowly. After 4 hours there was 
no detectable GST-tagged protein in S. cerevisiae lysate. After 19 hours, the GST-tagged 
recombinant protein products were visible, but the presence of multiple lower weight bands 
indicated that the products were heavily degraded. This concerning result urged the acquisition 
of an S. cerevisiae codon-optimized version of CnMIP1.  
III. G Sc-codon-optimized-CnMIP1 expression  
 The excessive degredation of protein expressed in Figure 10 led to the acquisition of an S. 
cerevisiae codon-optimized version of CnMIP1 (CnMIP1-Sc). The new DNA fragment was 
transformed into S. cerevisia along with pRS424 linearized with EcoRI and XhoI in order to 
perform homolgous recombination (see Materials and Methods). Protocols designed to recover 
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the plasmid from yeast proved unsuccessful with the transformed yeast. However, transformant 
colonies taken directly from the tranformation plate were capable of expressing recombinant 
CnPolG for up to five days after transformation. 
 
Figure 11. Expression of GST, ScPolG, and codon optimized CnPolG in S. cerevisiae. Western 
blot performed with GST antibody. Protein expressed using pRS424, pRS424-ScMIP1, and 
pRS424-CnMIP1#18 are represented. A band at 25 kDa is expected from GST, a band at 160 kDa 
is expected from ScPolG, and a 183 kDa band is expected from CnPolG. 
 
 In Figure 11 the pRS424 lanes showed that GST was still being produced robustly. The 
pRS424-ScMIP1 plasmid was producing minorly degraded ScPolG. Finally, the pRS424-
CnMIP1-Sc lanes showed that the transformant colonies from the homologous recombination 
plates could produce full-length CnPolG. The 5-hour time point contained less degraded protein 
than the 7-hour time point, so moving forward 5 hours would be considered the optimal 
induction time.  
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III. H Assessing Sc colonies for protein production   
 In order to show consistent ability for the homolgous recombination transformants to 
produce recombinant CnPolG, 14 different colonies were induced at 30 °C and assessed via 
western blot. 
  
 
Figure 12. Expression of CnPolG from 14 homologous recombination transformants. Western blot 
performed with GST antibody. 1-14 indicate 14 different S. cerevisiae colonies 5 hours after 
induction of protein expression with galactose.  
  The S. cerevisiae colonies assessed in Figure 12 showed that homologous recombination 
was consistently producing colonies capable of inducible protein expression. Though some of the 
colonies seemed to produce protein more robustly (lane 13), all of these colonies produced 
protein that was minorly degraded.  
 Moving forward these colonies were used in larger scale experiments. However, the 
protein expression phenotype was lost in these large-scale induction. Three to five days after 
transformation, even small scale inductions lost the ability to produce recombinant protein.  
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IV. Characterization of the Polymerase activity of CnPolG using M13 assays 
The M13 assay utilizes circular, single-stranded, viral DNA as a template for DNA 
polymerization. Results from this assay can be used to confirm polymerase activity of an 
enzyme, explore optimal buffer components, estimate the velocity of an enzyme’s polymerase 
activity and it can determine whether a polymerase is capable of strand displacement. 
IV. A CnPolG shows DNA polymerase activity 
 
Figure 13. M13 Rolling Circle assay utilizing polymerase and CnPolG. Single-stranded M13 DNA 
was used as template for both proteins. Products formed at the indicated time points in the presence 
of the polymerases were visualized on a 0.8% agarose gel. 
 
 The assay utilized the recombinant protein containing CnPolG with a N-terminal His6 tag 
and a C-terminal Strep-tag® (Figure 13). This double-tagged protein was acquired from Dr. 
Wallen.  Single-stranded M13 DNA annealed with M1326 primer was used as the template in these 
reactions and was represented by a band in the M13 DNA lane between 1.5 kb and 2 kb. Depletion 
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of template band intensity and appearance of higher molecular weight DNA species indicated successful 
polymerization of the single-stranded DNA template.   
T7 DNA polymerase was used as a control of the polymerization assay. It provides an 
example of a polymerase that does not perform strand displacement but, polymerizes DNA 
robustly. As seen in Figure 13, the T7 polymerase protein was able to utilize the M13 template 
for rapid polymerization, with most of the ssDNA being replicated by 10 minutes. Within an 
hour (T7 60 min lane) the fully replicated DNA manifested as two bands, at approximately 7 kb 
and 8 kb. Depletion of the template DNA band further confirmed that this assay was 
demonstrating efficient DNA polymerization. 
 Although CnPolG also showed polymerization activity, as indicated by two M13 bands 
after one hour, it was a much slower enzyme under these conditions in comparison to the T7 
polymerase.  There was minimal depletion of the ssDNA template after 2 minutes, and partial 
polymerization after 10 minutes. After 60 minutes there seemed to be a definitive end point for 
the DNA replication showing that CnPolG was capable of fully replicating the DNA template. It 
provided evidence that CnPolG does not perform strand displacement. It also showed that 
something else was occurring which caused a low weight DNA smear smaller than the original 
template. This could be the result of exonuclease activity.   
 
 
 
 
42 
 
IV. B CnPolG shows sensitivity to NaCl and different function depending on cation 
 
 
Figure 14. Effect of Mg2+, Mn2+ and low NaCl concentration on the CnPolG polymerase activity 
in the presence of a non-tailed primer. Products of the M13 Rolling Circle assay using His6-tagged 
CnPolG were visualized using a 0.8% agarose gel. This assay uses M13 ssDNA annealed with 
M1326 primer. The times of incubation, cations, and the salt concentrations used are indicated. 
 
 The M13 Assay represented by Figure 14 shows several interesting results. The M13 
ssDNA template showed up as a band at the expected size between 1.5 kb and 2 kb. However, 
the presence of lighter bands near 3 kb and 8 kb suggested that the template may be damaged or 
contaminated in some way.  Presence of these bands in the polymerase reactions, are therefore 
not necessarily indicative of full-length replication of the ssDNA template.  
 In order to investigate the effects of salt concentration on CnPolG polymerase activity, 
the concentration of NaCl was lowered. The standard concentration of sodium chloride in the 
assay is 20 mM. In the lanes marked as 5 mM NaCl, the concentration was reduced to 5 mM. All 
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other conditions are the same as the 5 mM MgCl2 lanes. The 5 mM NaCl lanes show the ssDNA 
template was depleted more rapidly than the 25 mM NaCl concentration lanes. The band at 
approximately 8 kb in the 60-minute 5 mM NaCl lane was significantly darker than the 60-
minute 5 mM MgCl2. This could mean that the CnPolG enzyme prefers a lower NaCl 
environment.  
 Another interesting difference between the 60-minute 5 mM NaCl lane and the 60-minute 
5 mM MgCl2 lane was that the low weight smear that appeared below the M13 ssDNA template 
was lighter in the 5 mM NaCl lane. This could mean that whatever was causing this smear may 
be mitigated by lowering NaCl concentration.  
 The last three lanes showed the result of performing this assay utilizing Mn2+ in place of 
using Mg2+ as a metal cation. This reaction mixture also utilized the standard 25 mM NaCl 
concentration. The 60-minute 5 mM MnCl2 lane showed that the M13 ssDNA template had been 
almost completely depleted similarly to the other 60-minute lanes in this gel. However, the 
appearance of a band at approximately 8 kb was not present in the 5 mM MnCl2 assay. This is 
puzzling because the low weight smear was also lighter than the other two 60-minute lanes. 
Since the ssDNA template was thoroughly depleted it is not clear what happened to all the DNA 
which should have presented itself as bands at a higher molecular weight.  
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IV. C CnPolG shows no evidence of strand displacement 
 
 
 
Figure 15. Effect of Mg2+, Mn2+ and low NaCl concentration on the CnPolG polymerase activity 
in the presence of a tailed primer. Products of M13 Rolling Circle assay using protein containing 
His6-tagged CnPolG were visualized using a 0.8% agarose gel. These results explore the effect of 
lowering NaCl concentration in the M13 buffer as well as utilizing MnCl2 as a metal cation in 
place of MgCl2. This assay uses M13 ssDNA annealed with M13 tailed
 primer. The times of 
incubation, cations, and the salt concentrations used are indicated. 
 
 The gel in Figure 15 represents the same assay conditions as the gel in Figure 14, but the 
primer annealed to the ssDNA Template includes a 10 bp non-complementary tail which was 
designed to increase the chance that the enzyme will perform stand displacement. In this assay it 
seemed that very similar results were achieved compared to Figure 14, including the two bands 
present above the ssDNA template. The addition of a non-complementary tail showed no 
45 
 
evidence that strand displacement was occurring when utilizing this enzyme for DNA 
polymerization.  
IV. D Divalent cations are essential for CnPolG function 
 
Figure 16. Effect of cations on the CnPolG polymerase activity.  Products of M13 Rolling Circle 
assay using His6-tagged CnPolG were visualized using a 0.8% agarose gel. The times of 
incubation, cations, and the salt concentrations used are indicated. This assay uses M13 ssDNA 
annealed with M1326 primer. 
 
 Figure 16 shows the results of an M13 assay used to display the essentiality of metal 
cations to the polymerase activity of CnPolG. The M13 DNA only lane contained the same two 
light bands above the expected size. Therefore, the light, roughly 8 kb band in the no metal 
cation lanes, can be explained by the presence of that same band in the DNA template. The no 
cation lanes also showed negligible depletion of the template DNA, and showed no band 
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appearing at roughly 7 kb (as in the bands which have shown fully polymerized DNA). Together 
this provided ample evidence that CnPolG was unable to polymerize DNA without a cation.  
 The 5 mM Mg2+ lanes showed that the addition of magnesium cations was sufficient for 
enabling DNA polymerization. Although in this assay it seemed that much of the DNA template 
remained unreplicated. The lanes containing 5 mM Mn2+ showed a similar result to the 
magnesium lanes but appeared to have used up more of the template DNA and produced slightly 
more fully replicated DNA. The difference between the results shown in Figure 16 here and the 
results shown in Figures 14 and 15 may be explained by the lower (5 mM) salt concentration. 
 The Mg2+ + Mn2+ lanes show that the addition of 5 mM magnesium and 5 mM 
manganese in the same reaction significantly increased template usage and fully replicated 
template DNA. This could be due to minor differences between these cations that allow the 
protein to work more efficiently when used together. This could also reflect the higher 
concentration of divalent metal cations. Both 5 mM and 10 mM concentrations were in extreme 
excess to the concentration of the enzyme, so the difference in concentration may not be the 
reason for the increased reaction velocity.  
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Chapter IV.  DISCUSSION 
 
A. The function of DNA polymerase gamma is essential in C. deneoformans 
C. neoformans/C.deneoformans (C. neoformans Serotype A and D that have now been 
classified as separate species) are obligate aerobes and therefore cannot survive without 
mitochondria. In the case of a facultative anaerobe like S. cerevisiae, loss of this gene leads to 
complete loss of mitochondria,24 so it is likely that this gene is in fact essential in a strict aerobe 
like C. neoformans/C. deneoformans as well.  In order to determine this, the gene was knocked 
down by RNAi.  The opposing GAL7 promoters were simultaneously induced in the presence of 
galactose, leading to the formation of two complementary mRNA sequences that ultimately form 
dsRNA. The Dicer enzyme then cuts the mRNAs into small interfering RNAs (siRNA). RNA-
induced silencing complex (RISC) uses the siRNAs to locate and degrade all mRNAs with 
complementary sequences. Expression of RNAi via the pIBB103 plasmid is variable in C. 
deneoformans cells, possibly because the plasmid is not maintained via a cryptococcal 
autonomous replication sequence (ARS), and is probably prone to plasmid loss.  That is why the 
presence of the ura5 fragment helps in assessing viability of the second gene. 
The tandem silencing of URA5 provides a negative selection factor to confirm efficient 
RNAi by utilizing 5-FOA. 5-FOA has no effect on strains of C. neoformans deficient of URA5 
because the URA5 protein product, orotidine 5’- phosphate decarboxylase, normally utilizes 
orotic acid to produce uracil. It is also capable of utilizing 5-FOA which produces a toxic 
compound known as 5-flourouracil. The RNAi experiments were performed in C. deneoformans 
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since this assay does not work as well in C. neoformans, presumably because the GAL7 
promoters in pIBB103 are from the former species.42 
More evidence that CnMIP1 is essential can be provided by replacing the native genomic 
promoter of this gene with the copper regulatable promoter, CTR4. This promoter has been 
shown to mediate high levels of expression in the absence of copper and tightly repress gene 
expression in the presence of copper.42 Replacing the native CnMIP1 promoter with the CTR4 
promoter could potentially be performed with relative ease using the CRIPSR/CAS9 system.43,44 
If using this molecular switch to turn off CnMIP1 expression proves fatal, it will provide great 
evidence of essentiality of this gene. 
B.  Expression of CnPolG in bacteria is a viable means of CnPolG expression  
 E. coli is commonly used as a first choice for expression of recombinant proteins due to 
the ease of the system and the low cost.  Therefore, initially the CnPolG protein was expressed in 
this system using the pET28a-CnMIP1 plasmid gifted by the Wallen lab.  This plasmid utilizes a 
kanamycin resistance gene as a selection factor and carries an in-frame N-terminal His6-tag so 
that the expressed protein may be purified using a Ni-column.  However, induction of the 
CnPolG protein at the standard temperature of 37˚C showed extensive degradation.  In order to 
try and purify the full-length protein, the eluants from the Ni-column were passed over an Ion-
exchange column. Ion-exchange chromatography works by loading the impure protein sample on 
to the column at a particular pH. Charges on the proteins bind opposite charges present in the 
column’s resin. Full-length CnPolG is presumed to have a different charge than the degraded 
products. Proteins with less exposed charged functional groups should elute from the column at 
low concentrations of NaCl compared to those with many exposed, charged functional groups. 
Therefore, incrementally increasing NaCl concentration in the elution buffer allows segregation 
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of the proteins. This treatment did lead to elimination of many of the smaller fragments, but the 
yield of full-length protein was still low. CnPolG is a large protein of 1421 amino acids, and with 
the His6 tag has a predicted mass of 158.7 kDa.  It is possible that the large size of the protein 
leads to steric strain inside the E. coli cells, or the protein has some sort of negative effect on the 
cells. Since this protein has shown a potential tendency to degrade DNA as observed by the 
appearance of a DNA smear below the size of the DNA template (Figure 13), it could be that this 
protein is degrading genomic E. coli DNA causing the bacteria to target this protein for 
degradation.  
Cryptococcal proteins may also need specific conditions of pH or temperature in order to 
fold correctly. Improper folding of this protein upon translation could also be increasing 
degradation45 and might be mitigated by co-expression of C. neoformans chaperones or by 
moving to a more closely related species to Cryptococcus.  
 In order to try and mitigate the degradation, the Wallen lab had already tried tagging this 
protein at both ends, with a Strep-tag at the C-terminus as well as a N-terminal His6. Even after 
scaling the experiment to 27 liter of growth media, yields of full-length protein were too low to 
justify the amount of supplies and effort this procedure demands.  
Growing E. coli in the presence of ethanol before induction of the protein with IPTG 
following the previously mention protocol39 has shown promising results. Ethanol is an 
amphipathic molecule. When it is exposed to bacterial cell membranes, it causes changes in 
membrane fluidity, membrane transport and membrane lipid composition.40 This causes an 
increase in DNA synthesis41 which could contribute to increased protein expression levels in the 
presence of ethanol. If the level of increase is high enough, this method could justify utilizing 
pRS424-CnMIP-His-Strep again to express protein in the presence of ethanol.   
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C.  Expression of CnPolG in yeast was clean but unstable  
 Considering the troubles encountered when expressing recombinant CnPolG in bacteria, 
moving to a different organism for protein expression seemed like a logical option. CnPolG is 
native to a eukaryotic yeast which utilizes a very different arsenal of cellular machinery to 
translate mRNA to protein. S. cerevisiae is also a eukaryotic yeast and methods of expressing 
recombinant protein have been well established in this organism.46   
 A modified pRS424 plasmid was chosen as the expression vector for yeast expression. 
This plasmid uses TRP1 to allow for growth on -TRP. It contains bacterial and yeast origins of 
replication to allow for rapid modifications using bacteria. The plasmid is also equipped with a 
GAL1 promoter to allow for expression of recombinant protein. GST followed by an HRV-3C 
site precede the multiple cloning site allowing for purification of the GST-tagged protein and 
removal of the GST-tag with HRV-3C protease. In this case the cloned CnMIP1 gene was 
oriented to tag the N-terminal end of CnPolG with GST. 
 Due to the inability of S. cerevisiae to efficiently splice introns from genomic DNA, only 
the coding sequence could be cloned into the pRS424 plasmid. The first method attempted was 
to use HiFi cloning which utilizes exonuclease, ligase and proofreading polymerase to piece 
together overlapping PCR products. CnMIP1 consists of four exons, so PCR products were 
generated of each exon with overlaps of their adjacent exons. The first and fourth exons 
contained overlaps with pRS424. Multiple attempts failed to generate the desired plasmid. 
 The plan was to use cDNA as a template for PCR which led to the results shown in 
Figures 6a and 6b. CnMIP1 coding sequence was then cloned in pTOPO with N-terminal XhoI 
and C-terminal EcoRI restriction sites. When cut with both restriction enzymes, ligation of the 
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gene into pRS424 was never successful. No plasmids recovered from post-ligation 
transformation showed any evidence of containing CnMIP1. Finally, pTOPO-CnMIP1 digested 
with EcoRI alone was ligated into pRS424. Twenty transformant colonies from this ligation were 
screened and only one of them contained the gene in the correct orientation. However, when 
used to express protein, this plasmid was producing a protein product far smaller than the 
expected molecular weight (Figure 9). Upon inspection by Sanger sequencing, it was revealed 
that this plasmid contained a small fragment from pTOPO and the mitochondrial targeting 
sequence which was intended to be left out. Correcting this plasmid (pRS424-CnMIP1#18) 
consisted of creating a primer that was an antiparallel copy of Exon1F, using these primers to 
produce a PCR product with overlapping ends, and using HiFi to ligate the ends together. All 
these steps required multiple attempts. This finally resulted in pRS424-CnMIP1. 
 Proper expression of the CnPolG was verified by western blot with GST antibody. 
Protein expressed with pRS424-CnMIP1 should result in a protein product of 188 kDa. The 
result of expression with this plasmid is shown in Figure 10. This could be explained by the long 
induction period, but undetectable levels of protein were being expressed in lesser amounts of 
time. Codon optimization of heterologous genes is a common tool that can lead to improvement 
of protein translation.47 The company GenScript was tasked with codon optimizing CnMIP1 to S. 
cerevisiae and cloning the codon optimized gene in pRS424. GenScript successfully codon 
optimized this gene and stored it in pFL39. However, all attempts made by this company to clone 
the gene into pRS424 failed. Attempts by the Wallen lab and Bose lab to produce a pRS424 
plasmid containing S. cerevisiae codon optimized CnMIP1 also failed. Transforming yeast with 
PCR products of BLO256 and BLO257 and pFL39-CnMIP1-Sc and pRS424 digested with XhoI 
and EcoRI seemed to be sufficient for homologous recombination, and protein expression was 
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verified by western blot using these transformant colonies (Figure 11). Attempts to recover 
plasmids from these colonies failed, and interestingly, after 3-5 days these colonies lost the 
protein expression phenotype.  
D. CnPolG is a polymerase that prefers low salt concentrations   
 CnPolG is capable of robust polymerase activity. Interestingly, the recommended NaCl 
concentration of 20 mM seems to cause CnPolG to function more slowly. DNA smearing below 
the M13 ssDNA template also seems to increase in the 100 mM salt lanes.  Human PolGA has 
been shown to reduce polymerase activity and increase exonuclease activity in the presence of 
high salt concentration.30 It could be that the low DNA smear is the result of the activation of the 
exonuclease domain in high NaCl concentration. When human PolGB is used with human 
PolGA, the salt tolerance of human PolGA increases. This could mean that CnPolG has a 
processivity cofactor similarly to human PolGA.  
E. CnPolG tagged with His6 and Strep outperforms protein tagged only with His6  
The single tagged CnPolG seems to polymerize DNA at a slower rate than the double 
tagged protein when the same conditions are used. This can be inferred because 10 minutes after 
the reaction was started, the DNA band is still at the same molecular weight as the template 
ssDNA using the single tagged protein (Figure 14), but at the 10 minute mark using the double 
tagged protein there is evidence that the M13 ssDNA is partially replicated (Figure 13). This may 
be due to some degraded protein products present in the final protein solution. It is possible that 
some of the degraded CnPolG is still capable of binding DNA without being able to polymerize 
that DNA. This would most likely slow down the reaction or prevent it in the first place. Seeing 
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that much of the template remains undepleted in these reactions, it would make sense that 
something is preventing the template from being used entirely. 
F. Mn2+ and Mg2+ effect CnPolG differently 
 This study has shown that CnPolG is incapable of DNA polymerization without the help 
of a divalent cation such as Mn2+ or Mg2+. This result was expected, as Family A polymerases 
require these cations to function. What is interesting about CnPolG is that it seems to utilize the 
M13 ssDNA template differently depending on which cation it has to work with. It has been 
previously shown that Mg2+ cations make human PolGA prefer to use DNA substrates while 
Mn2+ cations make it prefer RNA substrates.30 However, in these experiments it seems that the 
use of Mg2+ caused more fully replicated M13 DNA to appear while using up all the template 
differently than Mn2+  which used up the template but did not produce fully replicated DNA. This 
could be because the polymerase domain is activated more in the presence of Mg2+.  
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APPENDIX A 
 
 
 
A. Primers: 
Table 1. Primers used in this project 
Name  Description Sequence (5’ to 3’) Restrictio
n Enzyme 
BLO001 CnActin (F) CTTGGTCATTGACAATGGCTC NA 
BLO002 CnActin (R) CTTGGTCATTGACAATGGCTC NA 
BLO179 CnMIP1 localization F  GACAACGACTTCACCAATCCATGCG
CAAGGCGCTTGATATTTC 
NA 
BLO180  CnMIP1 localization 
R 
CTCGCCCTTGCTCACCATTGCTTGAA
ACTTCTTGCTAGAAGACAGAAC 
NA 
Exon1F Exon1-pRS424 
overlap 
AGTTCTGTTCCAGGGGCCCGAATTC
ATGAAACCATCGGATGCACC 
EcoRI 
Exon1R Exon1-exon2 overlap CGAATCTTCCTAACTCGAGGCTGGC
CATAGC 
NA 
Exon2F Exon2-exon1 overlap GGCCAGCCTCGAGTTAGGAAGATTC
GCAAATCCAAATTGC 
NA 
Exon2R Exon2-exon3 overlap TTCCGCCGCGGGCCGCTCTTGCTTTG
CCCCG 
NA 
Exon3F Exon3-exon2 overlap CAAAGCAAGAGCGGCCCGCGGCGG
AATCCTG 
NA 
Exon3R Exon3-exon4 overlap GATGAGGTGATATCTTGAGTTGTGG
GTGTCCAGTCAAGC 
NA 
Exon4F Exon4-exon3 overlap CCCACAACTCAAGATATCACCTCAT
CCAATGATG 
NA 
Exon4R Exon4-pRS424 
overlap 
TAGCTTGGCCGGGCCCCCCCTCGAG
TCATTGAAACTTCTTGCTAG 
XhoI 
BLO245 Exon1F Antiparallel GGTGCATCCGATGGTTTCATGAATT
CGGGCCCCTGGAACAGAACT 
EcoRI 
BLO246 CnMIP1ΔN TTCTGTTCCAGGGGCCCGAATTCAT
GCGGAATCCTGTTGGGGTCCAAAT 
XhoI 
BLO247 CnMIP1ΔN ATTTGGACCCCAACAGGATTCCGCA
TGAATTCGGGCCCCTGGAACAGAA 
EcoRI 
BLO248 pRS424-PIF1 HiFi F AGTTCTGTTCCAGGGGCCCAAGCCT
ATGCCAAAACCAGGTTTCTACG 
EcoRI 
BLO249 pRS424-PIF1 HiFi R TAGCTTGGCCGGGCCCCCCCTCGAG
CTAATATAATATACCAAAGTTA 
XhoI 
BLO250 pRS424-PIF2 HiFi F AGTTCTGTTCCAGGGGCCCAAGCCT
ATGCCTATTCTTACGGCCCGCACACT
C 
EcoRI 
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BLO251 pRS424-PIF2 HiFi R TAGCTTGGCCGGGCCCCCCCTCGAG
TCATACGAGATTCAAATCCTTGA 
XhoI 
BLO252 pRS424-CnMIP1 R 
EcorI  
CTTCTTGAATTCTCATTGAAACTTCT
TGCTAG 
EcoRI 
BLO253 CnMIP1-Sc F CACAACGAATTCATGAAACCATCAG
ATGCTC 
EcoRI 
BLO254 CnMIP1-Sc R CACAACGAATTCTTGGAATTTCTTA
GAAGAAGAC 
EcoRI 
BLO255 pRS424-NΔ-CnMIP1-
Sc HR F 
CCGAATTCGATATCAAGCTTATCGA
TACCGTCGACCAGAAATCCAGTTGG
TGTTC 
NA 
BLO256 pRS424-NΔ-CnMIP-
Sc HR R 
GCCCGGAATTAGCTTGGCCGGGCCC
CCCCTCGATTATTGGAATTTCTTAGA
AGAA 
XhoI 
BLO257 pRS424-NΔ-CnMIP1-
Sc HR F 
ATCAAGCTTATCGATACCGTCGACC
GTTAACAGAAATCCAGTTGGTGTTC 
EcoRI 
BLO273 pRS424-insert Screen 
F 
TTGGATATTAGATACGGTGTTTCG  NA 
BLO274 pRS424-insert Screen 
R 
GTGAACCATCACCCTAATCAAGTT  NA 
BLO275 M1326 CGCGTACTATGGTTGCTTTGACGAG
C 
NA 
BLO276 M13 tailed CCGCGACCATCGCGTACTATGGTTG
CTTTGACGAGC 
NA 
 
B. Fungal Strains 
Table 2. Fungal strains used in this project 
IB# Strain 
name 
Species Mating 
Type 
Description (genotypes 
etc) 
Source 
IBCN02 KN99 C. neoformans  MAT 
alpha 
WT Heitman lab 
IBCN43 JEC21 C. deneoformans MAT 
alpha 
WT (alias 4659) Doering lab 
IBCN64 cap59 C. neoformans  MAT 
alpha 
HYG (alias TDY875) Lodge lab 
IBF42 FM113 S. cerevisiae  MAT 
alpha  
ura3–52, trp1–289, leu2–
3, 112, prb1–1122, prc1–
407, pep4‐3 
Bose lab 
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C. Bacterial Strains 
Table 3. Bacterial strains used in this project 
E. coli Strain Description Source 
NEB 5-alpha fhuA2 a(argF-lacZ) U169 phoA glnV44 a80a(lacZ) 
M15 gyrA96 
New England 
Biolabs  
BL21(DE3) F-ompT hsdSB (rB-mB-) gal dcm (DE3) New England 
Biolabs  
XL-1 blue  recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´ proAB lacIqZ∆M15 Tn10 (Tetr)] 
Wallen lab 
 
D. Plasmids 
Table 4. Plasmids used in this project 
Plasmid Name Description Markers Source 
pIBB103 RNAi plasmid (URA5 knockdown) Amp/NEOG418 Bose lab  
pIBB103-MIP1i RNAi plasmid (CnMIP1/URA5 
Knockdown) 
Amp/NEOG418  Boggs thesis  
pET28a-
CnMIP1 
CnPolG bacterial expression plasmid 
(N-terminal His6) 
Kan Wallen lab 
pET28a-
CnMIP1-His-
Strep 
CnPolG bacterial expression plasmid 
(N-terminal His6/C-terminal Strep) 
Kan Wallen lab 
pTOPO Gene storage plasmid Kan ThermoFisher 
pTOPO-
CnMIP1 
Gene storage plasmid with CnMIP1 Kan This work 
pRS424 Yeast protein overexpression plasmid 
(N-terminal GST) 
Amp/TRP1 Wallen lab  
pRS424-
ScMIP1 
ScPolG yeast expression plasmid (N-
terminal GST) 
Amp/TRP1 Wallen lab   
pRS424-
CnMIP1#18 
CnPolG yeast expression plasmid 
containing excess undesired DNA 
sequence (N-terminal GST)  
Amp/TRP1 This work  
pRS424-
CnMIP1 
CnPolG yeast expression plasmid (N-
terminal GST) 
Amp/TRP1 This work  
pFL39-
CnMIP1-Sc 
CnPolG yeast expression plasmid codon 
optimized for use in S. cerevisiae (N-
terminal GST) 
Amp/TRP1 Wallen lab 
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E. Media Recipes  
Table 5. Recipe for Lysogen Broth, Miller (LB) 
Component g/liter 
Tryptone 10  
Yeast Extract                       5  
Sodium Chloride                5  
 
Table 6. Recipe for Yeast Peptone Dextrose media (YPD)                   
Component g/liter 
Tryptone   20 
Yeast Extract                      10 
Dextrose   20 
 
Table 7. Recipe for Synthetic complete minus tryptophan (-TRP) 
Component g/liter 
Yeast Nitrogen Base Without Amino Acids 1.92 
Synthetic Dropout Mix Minus Tryptophan 6.7 
Glucose 5  
 
Table 8. Recipe for SCGL (pH 5-6)          
Component g or ml /liter 
Yeast Nitrogen Base Without Amino Acids 1.92 g/L 
Synthetic Dropout Mix Minus Tryptophan 6.7 g/L 
Glucose 1 g/L 
Glycerol 20 ml/L 
Lactic Acid 5 l/L 
 
Table 9. Recipe for YPGL (pH 5-6)          
Component g or ml /liter 
Yeast Extract 10g/L 
Peptone 20 g/L 
Glucose 2 g/L 
Glycerol 30 ml/L 
Lactic Acid 5 l/L 
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Table 10. Recipe for 5-FOA plates solution 1 
Solution I Components Unit ingredient 
  
Glucose 2 g 
Bacto agar 2 g 
Uranine and adenine dropout mix 87 mg 
10M NaOH 10 µl 
Di H2O 50 ml 
 
Table 11. Recipe for 5-FOA plates solution 2 
Solution II Components Unit ingredient 
Yeast Nitrogen Base 10 ml 
5 – Flouro Orotic Acid 0.1 g 
100x uracil  600 µl 
1x adenine 1 ml 
 
Solution I. is autoclaved for 20 minutes and allowed to cool to ~80 °C. Solution II is filter 
sterilized using a vacuum filter sterilization system. The two solutions are mixed and poured into 
sterile 15 ml petri dishes and allowed to solidify in the absence of light. The plates are stored in 
the absence of light. 
